Large Cell Lung Carcinoma Active Not Recruiting Phase 2 Trials for Pegfilgrastim (DB00019)

Also known as: Carcinoma, Large Cell Lung

IndicationStatusPhase
DBCOND0044133 (Large Cell Lung Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00334815Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment